Characterization of the nasopharyngeal microbiome in patients with Kawasaki disease.


Journal

Anales de pediatria
ISSN: 2341-2879
Titre abrégé: An Pediatr (Engl Ed)
Pays: Spain
ID NLM: 101765626

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 16 07 2021
accepted: 16 11 2021
pubmed: 15 10 2022
medline: 9 11 2022
entrez: 14 10 2022
Statut: ppublish

Résumé

The aetiology of Kawasaki disease (KD) remains unknown. Several studies have linked the human microbiome with some diseases. However, there are limited studies on the role of the respiratory microbiome in KD. The aim of our study was to make a more thorough analysis of the causes and processes that increase the susceptibility to KD. Case-control study comparing the respiratory microbiome of KD patients with that of healthy children. The V3-V4 region of the 16S rRNA bacterial gene and 16 respiratory viruses were analysed by real-time polimerase-chain reaction. We used the Ribosomal Database Project (RDP) version 11.5 (taxonomic assignment). The initial sample included 11 cases and 11 controls matched for age, sex and seasonality. One of the cases was excluded to poor sample quality. The final analysis included 10 cases and 10 controls. In the case group, the analysis detected Haemophilus, Moraxella, Streptococcus and Corynebacterium species (27.62%, 19.71%, 25.28%, 11.86%, respectively). In the control group, it found Haemophilus, Streptococcus, Moraxella, and Dolosigranulum species (38.59%, 23.71%, 16.08, 8.93%, respectively). We found a higher relative abundance of Corynebacterium in patients with KD (11.86% vs. 1.55%; P = 0.004). To our knowledge, this is the first study that has found differences in the composition of the respiratory microbiome between patients with KD and healthy controls. The relative abundance of Corynebacterium spp. was greater in the KD group. This study shows differences in the microbiome between cases and controls, which suggests that the microbiome may play a role in facilitating the development of KD.

Identifiants

pubmed: 36241544
pii: S2341-2879(22)00176-4
doi: 10.1016/j.anpede.2022.08.001
pii:
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

300-309

Informations de copyright

Copyright © 2022 Asociación Española de Pediatría. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Judith Sánchez-Manubens (J)

Sección de Reumatología Pediátrica, Servicio de Pediatría, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain; Unidad de Reumatología Pediátrica, Servicio de Pediatría, Hospital Parc Taulí, Sabadell, Barcelona, Spain; Servicio de Pediatría, Universitat Autònoma de Barcelona, Bellaterra, Cerdanyola del Vallès, Barcelona, Spain; Institut de recerca Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain. Electronic address: judith.sanchezm@sjd.es.

Desirée Henares (D)

Institut de recerca Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain; Unidad de Microbiología Molecular, Laboratorio, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain; CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain.

Carmen Muñoz-Almagro (C)

Unidad de Microbiología Molecular, Laboratorio, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain; CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain; Departamento de Medicina, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, Spain.

Pedro Brotons de Los Reyes (P)

Unidad de Microbiología Molecular, Laboratorio, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain; CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain; Departamento de Medicina, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, Spain.

Natalia Timoneda (N)

Unidad de Microbiología Molecular, Laboratorio, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain; CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain.

Jordi Antón (J)

Sección de Reumatología Pediátrica, Servicio de Pediatría, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain; Institut de recerca Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain; Departamento de Cirugía y Especialidades Médico-quirúrgicas, Universitat de Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH